United Laboratories reports steady revenue, highlights R&D progress

The United Laboratories International Holdings (HKEX: 3933) reported steady revenue of RMB13.7589 billion for the year 2024, according to its annual results announcement. Profit attributable to owners decreased slightly by 1.5% to RMB2.6597 billion, with basic earnings per share at RMB146.39 cents. The board has recommended a final dividend of RMB28 cents per share and a special dividend of RMB12 cents per share, bringing the total dividend for the year to RMB56 cents.